Professor Mat During carried out clinical trials in a gene therapy treatment on Nathan Klien and eleven others with advanced Parkinson's. Klien made headlines across the U.S. and around the world. And the trials were deemed a success. Fast forward to 2008 and the company involved in those early trials Neurologix
www.neurologix.net are underway with a second gene therapy trial with full FDA approval
Ceregene are also starting phase two trials with their innovative cere-120 program and their gene therapy delivery of neurturin appears very exciting.
Will there be a cure.......YES......
How long.............................................. ...........